Therapeutics News

During the course of 6 months, once-monthly triple antibiotic treatment helped improve, but did not clear, granuloma annulare, according to study findings.

Researchers discovered that a combination of afamelanotide and NB-UV-B phototherapy resulted in statistically significant superior and faster repigmentation compared with NB-UV-B monotherapy.

In patients with chronic plaque-type psoriasis, pioglitazone therapy taken with methotrexate caused greater reductions in psoriasis area and severity index scores than methotrexate alone but did not significantly improve quality of life, according to study findings.

AbbVie announced positive results from its phase 3 study of Humira for the treatment of hidradenitis suppurativa at the 44th Annual European Society for Dermatological Research Meeting, according to a company press release.

WASHINGTON, D.C. — An early positive clinical response to oritavancin within 48 to 72 hours was highly predictive of an eventual cure in adult patients with acute bacterial skin and skin structure infections, according to recent data presented at ICAAC 2014.

Female donor and female donor to male recipient sex mismatch had a significant association with the development of vitiligo and/or alopecia areata in patients with chronic graft-versus-host disease, according to researchers.

Psoriasis treatments have evolved from a step-by-step approach to more targeted therapies catered to the specific needs of each patient, according to a consumer update from the U.S. Food and Drug Administration.

Ionic liquids may be an effective resource in combating bacterial skin infections protected by biofilm, according to recent study data published in the Proceedings of the National Academy of Science.

In a retrospective review of patients with acquired idiopathic anhidrosis, researchers found almost all cases occurred among younger, mostly healthy Chinese men, indicating a potential genetic predisposition.

Researchers found transient elastography and FibroTest to be effective, noninvasive tools for hepatoxicity monitoring in patients with psoriasis who are treated with methotrexate.